Scientia Ventures

Scientia Ventures is a venture capital firm established in 2006 and located in New York, New York. The firm specializes in investing in early to mid-stage technology companies within the healthcare sector, focusing on areas such as computational biology and chemistry, the digitization of medicine, digital therapies, and traditional drug development. By targeting companies at the forefront of life sciences innovation, Scientia Ventures aims to support advancements that can significantly impact healthcare and improve patient outcomes.

John Dessouki

Principal

Jonathan Finn

General Partner

Harry Glorikian

General Partner

Rory Riggs

General Partner

2 past transactions

Intelinair

Series B in 2021
IntelinAir, Inc. is an aerial imagery analytics company that specializes in providing actionable intelligence for the agriculture sector. Established in 2015, the company aims to enhance operational efficiency, crop yields, and profitability for farmers through data-driven decision-making. IntelinAir leverages a combination of traditional computer vision, deep learning methodologies, and agronomic science to analyze aerial data. Their flagship solution, AG-MRI™, serves as a field health monitoring and early-warning system, allowing farmers to manage their operations with greater confidence and proactivity. Additionally, IntelinAir offers SafeSmart technology, which includes UAV platforms designed for precision flight and data analysis, supporting both academic research and practical applications in agriculture. The company operates from dual headquarters in San Jose, California, and Champaign, Illinois.

1910 Genetics

Seed Round in 2020
AI for new drug discovery
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.